2 recruiting, 2 unknown, 1 terminated. 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Thrombotic thrombocytopenic purpura, acquired: new trials by email Literature Review of Thrombotic thrombocytopenic purpura, acquired trials Research Report on Thrombotic thrombocytopenic purpura, acquired
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura Thrombotic Thrombocytopenic Purpura, Acquired | Recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 40 | 2025-10-01 | 2026-04-14 | |
| Association of TNFAIP3 With Immune-mediated TTP blood sampling - Thrombotic Thrombocytopenic Purpura, Acquired | Not applicable | Recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 400 | 2025-04-07 | 2026-03-27 |
| A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI) Thrombotic Thrombocytopenic Purpura, Acquired | Unknown | Catholic University of the Sacred Heart | 50 | 2022-03-01 | 2022-03-02 | |
| Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP Bortezomib Injection - Thrombotic Thrombocytopenic Purpura, Acquired | Phase 4 | Unknown | Peking Union Medical College Hospital | 30 | 2021-12-01 | 2021-11-26 |
| Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP Caplacizumab - Thrombotic Thrombocytopenic Purpura, Acquired | Phase 2 | Terminated | University Hospital, Rouen | 58 | 2021-04-26 | 2026-02-20 |
Purpura, Thrombotic Thrombocytopenic (2)
Blood Coagulation Disorders (2) · Blood Platelet Disorders (2) · Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhage (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Purpura (2) · Purpura, Thrombocytopenic (2) · Signs and Symptoms (2) · Skin Manifestations (2) · Thrombocytopenia (2) · Thrombophilia (2) · Thrombotic Microangiopathies (2)
Blood Specimen Collection (1) · Bortezomib (1) · Plasma Exchange (1) · caplacizumab (1)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (2) · Catholic University of the Sacred Heart (1) · Peking Union Medical College Hospital (1) · University Hospital, Rouen (1)
Italy (3) · China (1) · France (1) · Martinique (1)
PMID 15647017, PMID 18028271, PMID 20033409, PMID 2062331, PMID 21636861, PMID 22404639, PMID 22624596, PMID 22790258, PMID 24869941, PMID 25573992, PMID 25784681, PMID 26245827, PMID 26907228, PMID 27060171, PMID 27590601, PMID 28259521, PMID 30046703, PMID 32634236